These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Permissive changes in the neuraminidase play a dominant role in improving the viral fitness of oseltamivir-resistant seasonal influenza A(H1N1) strains. Abed Y; Pizzorno A; Bouhy X; Boivin G Antiviral Res; 2015 Feb; 114():57-61. PubMed ID: 25512229 [TBL] [Abstract][Full Text] [Related]
9. Life cycle synchronization is a viral drug resistance mechanism. Neagu IA; Olejarz J; Freeman M; Rosenbloom DIS; Nowak MA; Hill AL PLoS Comput Biol; 2018 Feb; 14(2):e1005947. PubMed ID: 29447150 [TBL] [Abstract][Full Text] [Related]
10. Evolutionary analysis of human immunodeficiency virus type 1 therapies based on conditionally replicating vectors. Ke R; Lloyd-Smith JO PLoS Comput Biol; 2012; 8(10):e1002744. PubMed ID: 23133349 [TBL] [Abstract][Full Text] [Related]
11. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Bloom JD; Gong LI; Baltimore D Science; 2010 Jun; 328(5983):1272-5. PubMed ID: 20522774 [TBL] [Abstract][Full Text] [Related]
12. Evolution of oseltamivir resistance mutations in Influenza A(H1N1) and A(H3N2) viruses during selection in experimentally infected mice. Pizzorno A; Abed Y; Plante PL; Carbonneau J; Baz M; Hamelin MÈ; Corbeil J; Boivin G Antimicrob Agents Chemother; 2014 Nov; 58(11):6398-405. PubMed ID: 25114143 [TBL] [Abstract][Full Text] [Related]
13. Can modulation of viral fitness represent a target for anti-HIV-1 strategies? Clementi M New Microbiol; 2004 Jul; 27(3):207-14. PubMed ID: 15460522 [TBL] [Abstract][Full Text] [Related]
15. Genomic diversity of oseltamivir-resistant influenza virus A (H1N1), Luxembourg, 2007-08. Gerloff NA; Kremer JR; Mossong J; Opp M; Muller CP Emerg Infect Dis; 2009 Sep; 15(9):1523-4. PubMed ID: 19788831 [No Abstract] [Full Text] [Related]
16. Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases. Nijhuis M; van Maarseveen NM; Boucher CA Handb Exp Pharmacol; 2009; (189):299-320. PubMed ID: 19048205 [TBL] [Abstract][Full Text] [Related]
17. Community spread and late season increased incidence of oseltamivir-resistant influenza A(H1N1) viruses in Norway 2016. Bragstad K; Hungnes O; Litleskare I; Nyrerød HC; Dorenberg DH; Hauge SH Influenza Other Respir Viruses; 2019 Jul; 13(4):372-381. PubMed ID: 30834715 [TBL] [Abstract][Full Text] [Related]
18. Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010-2015. Tewawong N; Marathe BM; Poovorawan Y; Vongpunsawad S; Webby RJ; Govorkova EA PLoS One; 2018; 13(1):e0190877. PubMed ID: 29324781 [TBL] [Abstract][Full Text] [Related]